Systems and methods for treating human inflammatory and proliferative diseases, with a combination of compounds, or a bifunctional compound,that provides fatty acid metabolism and glycolysis inhibition

Details for Australian Patent Application No. 2006242667 (hide)

Owner The Regents of the University of Colorado

Inventors Newell, M. Karen Rogers; Newell, Evan

Agent Pizzeys

Pub. Number AU-A-2006242667

PCT Pub. Number WO2006/118821

Priority 60/676,861 02.05.05 US

Filing date 20 April 2006

Wipo publication date 9 November 2006

International Classifications

A61K 31/325 (2006.01) - Carbamic acids

Event Publications

20 December 2007 PCT application entered the National Phase

  PCT publication WO2006/118821 Priority application(s): WO2006/118821

1 April 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006242677-MAC multiplexing and TFC selection procedure for enhanced uplink

2006242663-Paracorporeal respiratory assist lung